Experimental measurements of Space Station antenna patterns at 60 GHz for EM analysis verification

Complex body scattering is a major problem facing the electromagnetic researcher today. Computer codes are one important method for predicting such scattering. With funding from Langley, Ohio State University has developed such a code. A 30:1 scale model of the Space Station was constructed to be used as a scattering target in the verification of this code. The purpose here is to document the methods used to make these measurements and present the results which will be used by others for code verification

Information Privacy in a Globally Networked Society: Implications for IS Research

This paper presents an extended discussion of issues associated with the role of information privacy in IS research. This discussion was initiated in conjunction with a panel session at ICIS 2002. Following the conference, each of the panelists reworked and extended their position statements, and provided a commentary on the position statements of the other panelists. The paper is framed with head and tail pieces written by the panel chair. The result is a (unique and provocative) blend of opinion and commentary on a topic that is of importance to IS research in the globally networked society in which we all live. IS researchers will find research questions, research conundrums, and research advice in equal measure

Is tapentadol different from classical opioids?: a review of the evidence

Tapentadol is a single molecule able to deliver analgesia by two distinct mechanisms, a feature which differentiates it from many other analgesics. Pre-clinical data demonstrate two mechanisms of action: mu-opioid receptor agonist activity and noradrenaline re-uptake inhibition. From these, one may predict that tapentadol would be applicable across a broad spectrum of pain from nociceptive to neuropathic. The evidence in animal models suggests that norepinephrine re-uptake inhibition (NRI) is a key mechanism and may even predominate over opioid actions in chronic (and especially neuropathic) pain states, reinforcing that tapentadol is different to classical opioids and may, therefore, be an a priori choice for the treatment of neuropathic and mixed pain. The clinical studies and subsequent practice experience and surveillance support the concept of opioid and non-opioid mechanisms of action. The reduced incidence of some of the typical opioid-induced side effects, compared to equianalgesic doses of classical opioids, supports the hypothesis that tapentadol analgesia is only partially mediated by opioid agonist mechanisms. Both the pre-clinical and clinical profiles appear to be differentiated from those of classical opioids

Le Forum, Vol. 40 No. 2

https://digitalcommons.library.umaine.edu/francoamericain_forum/1087/thumbnail.jp

Le FORUM, Vol. 36 No. 3

https://digitalcommons.library.umaine.edu/francoamericain_forum/1034/thumbnail.jp

Le FORUM, Vol. 37 No. 1

https://digitalcommons.library.umaine.edu/francoamericain_forum/1036/thumbnail.jp

Le FORUM, Vol. 39 No. 3

https://digitalcommons.library.umaine.edu/francoamericain_forum/1046/thumbnail.jp

Le FORUM, Vol. 38 No. 4

https://digitalcommons.library.umaine.edu/francoamericain_forum/1043/thumbnail.jp

Le FORUM, Vol. 39 No. 1

https://digitalcommons.library.umaine.edu/francoamericain_forum/1044/thumbnail.jp

Le FORUM, Vol. 37 No. 3

https://digitalcommons.library.umaine.edu/francoamericain_forum/1038/thumbnail.jp